Status:
RECRUITING
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
Lead Sponsor:
University of Florida
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Papillomavirus Vaccines
Eligibility:
All Genders
8-99 years
Phase:
NA
Brief Summary
There are three main objectives of the protocol. First, we will evaluate the added clinical- and cost- effectiveness of parent-targeted motivational aids (reminder/recall and phone-based MI) alone and...
Detailed Description
There are three main objectives of the protocol. First, we will evaluate the added clinical- and cost-effectiveness of parent-targeted motivational aids (reminder/recall and phone-based MI) alone and ...
Eligibility Criteria
Inclusion
- Adolescents Age 8- to 12-years-old Visited participating clinic in past year or during study No records of receiving both HPV vaccine doses
- Providers Provide 9- to 12-year-old patients primary care Practice at a participating clinic
Exclusion
- Adolescents Out of age range
- Providers Unwilling to consent
Key Trial Info
Start Date :
December 9 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2027
Estimated Enrollment :
4630 Patients enrolled
Trial Details
Trial ID
NCT06535139
Start Date
December 9 2024
End Date
July 1 2027
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Florida
Gainesville, Florida, United States, 32608